Programme

Programme of the Patients meeting
10:00 - 12:00

stationary – without registration

• 10:00 - 10:10
  Welcoming the patients, their families and other conference participants
  Prof. Alicja Hubalewska-Dydejczyk, Assoc. Prof. Aleksandra Gilis-Januszewska
   
• 10:10 - 10:40
  Lecture: Pituitary diseases – Diagnostics, treatment, long-term control of the disease complications.
  Assoc. Prof. Aleksanda Gilis-Januszewska
   
• 10:40 - 11:30
  Discussion forum with patients’ participation

- disease experience and the quality of life of the patients with pituitary diseases

- the importance of cooperation with patients, their families, and the medical team involved in the diagnostic process and the therapy in Cushing syndrome, acromegaly, hypopituitarism, and other pituitary diseases

• 11:30 - 12:00
  Mood disorders and cognitive disorders in pituitary diseases, how to deal with them? – Patient perspective and recommendations psychologist
  MSc Kinga Ciesielska
  
  The end of the meeting
   

Programme of the conference and the workshops for the doctors
Diagnostics and the treatment of acromegaly, hypercortisolemia and hypopituitarism complications in long-term medical care
13:30 - 17:15

stationary/online – mandatory registration

• 13:30 - 14:00 
  Lunch
   
• 14:00 - 14:05
  Welcoming of the conference participants
   
• 14:05 - 14:30 
  Complications of long-term somatotroph pituitary insufficiency – the benefits of the growth hormone treatment in adults
  Prof. Alicja Hubalewska-Dydejczyk
  
  
• 14:30 - 14:50
  Cardiometabolic complications of acromegaly, early diagnostics, prevention and treatment 
  Assoc. Prof. Aleksandra Gilis-Januszewska
   
• 14:50 - 15:10
   Liver function disorders during the Cushing syndrome treatment – diagnosis, prophylaxis and treatment
  Mari Minasyan, MD
• 15:10 - 15:25
   Coffee break

The workshop session – the multidisciplinary board of experts

Prof. Grzegorz Zieliński, Prof. Wojciech Bik, Renata Orłowska-Florek MD, PhD 

• 15:25 - 16:00
  Treatment of patients with growth hormone deficiency (adults and during) the transition.
  Session under the patronage of Sandoz company.
    
  
  • 15.25 - 15.40 
    The patient with panhypopituitarism during the transition – the adjustment of the growth hormone dose Prof. Małgorzata Wójcik
     
  • 15:40 - 15:50
    Patient with long-term panhypopotuitarism qualified to the growth hormone treatment as a part of a B111 programme – inclusion criteria and the principles of the monitoring
    Radosław Kacorzyk, MD 
    
    
  • 15:50 - 16:00
    Growth hormone treatment of the hypopituitarism – therapeutic problems
    Anna Watras, MD
    
    
• 16.00 - 16.45
  Treatment of the patients with acromegaly and hypercortisolemia complications
   
  • 16.00 - 16.15 
    Patient with acromegaly – the influence of the treatment escalation as a part of the B99 programme on the advanced disease complications: diabetes, hypertension, and mood disorders 
    Renata Orłowska-Florek MD, PhD/ Aleksandra Młodożeniec MD
     
  • 16:15 - 16:25 
    Patient with a long-term course of acromegaly successfully treated with first-generation SSA with pronounced bone and joint changes and osteoporosis
    Anna Bogusławska, MD
     
  • 16:25 - 16:35 
    Patient with an aggressive course of acromegaly – therapeutic approach
    Karol Ciszek, MD 
     
  • 16:35 - 16:45 
    Therapeutic approach in the severe hypokalemia in the course of Cushing syndrome
    Aleksandra Gamrat, MD
     
• 16:45 - 17:00

Discussion and the conclusions